Search research articles
Contact Us
Filters
Showing results (71-80 of 157) with videos related to
Page
of 16
Sort By:
Oncotarget
|
April 19, 2017
Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase
Corinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, et al.
Journal of the American Academy of Dermatology
|
April 25, 2009
Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients
Friedegund Meier, Emmanuella Guenova, Stephan Clasen, et al.
Plos One
|
December 7, 2013
Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy
Benjamin Weide, Sabina Richter, Petra Büttner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 18, 2023
Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafusp
Jessica C Hassel, Carola Berking, Andrea Forschner, et al.
JMIR Cancer
|
June 14, 2022
Understanding the Lived Experiences of Patients With Melanoma: Real-World Evidence Generated Through a European Social Media Listening Analysis
Jyoti Chauhan, Sathyaraj Aasaithambi, Iván Márquez-Rodas, et al.
Plos One
|
May 3, 2013
Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis
Benjamin Weide, Christine Faller, Petra Büttner, et al.
BMJ Open
|
December 21, 2016
Study protocol for a prospective, non-controlled, multicentre clinical study to evaluate the diagnostic accuracy of a stepwise two-photon excited melanin fluorescence in pigmented lesions suspicious for melanoma (FLIMMA study)
Christine Fink, Maja Hofmann, Agata Jagoda, et al.
International Journal of Cancer
|
November 11, 2025
Characterization of long-term survivors with liver metastases from uveal melanoma diagnosed between 2005 and 2021
Jona Laukhuf, Lisa Wiens, Gerd Grözinger, et al.
Cancers
|
April 26, 2020
Primary Resistance to PD-1-Based Immunotherapy-A Study in 319 Patients with Stage IV Melanoma
Teresa Amaral, Olivia Seeber, Edgar Mersi, et al.
Diagnostics (Basel, Switzerland)
|
September 23, 2022
Development of a Hybrid-Imaging-Based Prognostic Index for Metastasized-Melanoma Patients in Whole-Body 18F-FDG PET/CT and PET/MRI Data
Thomas Küstner, Jonas Vogel, Tobias Hepp, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 157) with videos related to
Sort By:
Page
of 16
Oncotarget
|
April 19, 2017
Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase
Corinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, et al.
Journal of the American Academy of Dermatology
|
April 25, 2009
Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients
Friedegund Meier, Emmanuella Guenova, Stephan Clasen, et al.
Plos One
|
December 7, 2013
Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy
Benjamin Weide, Sabina Richter, Petra Büttner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 18, 2023
Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafusp
Jessica C Hassel, Carola Berking, Andrea Forschner, et al.
JMIR Cancer
|
June 14, 2022
Understanding the Lived Experiences of Patients With Melanoma: Real-World Evidence Generated Through a European Social Media Listening Analysis
Jyoti Chauhan, Sathyaraj Aasaithambi, Iván Márquez-Rodas, et al.
Plos One
|
May 3, 2013
Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis
Benjamin Weide, Christine Faller, Petra Büttner, et al.
BMJ Open
|
December 21, 2016
Study protocol for a prospective, non-controlled, multicentre clinical study to evaluate the diagnostic accuracy of a stepwise two-photon excited melanin fluorescence in pigmented lesions suspicious for melanoma (FLIMMA study)
Christine Fink, Maja Hofmann, Agata Jagoda, et al.
International Journal of Cancer
|
November 11, 2025
Characterization of long-term survivors with liver metastases from uveal melanoma diagnosed between 2005 and 2021
Jona Laukhuf, Lisa Wiens, Gerd Grözinger, et al.
Cancers
|
April 26, 2020
Primary Resistance to PD-1-Based Immunotherapy-A Study in 319 Patients with Stage IV Melanoma
Teresa Amaral, Olivia Seeber, Edgar Mersi, et al.
Diagnostics (Basel, Switzerland)
|
September 23, 2022
Development of a Hybrid-Imaging-Based Prognostic Index for Metastasized-Melanoma Patients in Whole-Body 18F-FDG PET/CT and PET/MRI Data
Thomas Küstner, Jonas Vogel, Tobias Hepp, et al.
Page
of 16